Literature DB >> 16558013

Cephalexin: absorption and excretion as related to renal function and hemodialysis.

B E Reisberg1, J M Mandelbaum.   

Abstract

Cephalexin is a new semisynthetic cephalosporin C derivative, which is well absorbed from the gastrointestinal tract and excreted in high concentration in the urine. Even in patients with impaired renal function, the concentrations of cephalexin present in the urine are adequate for the treatment of most urinary tract infections produced by Escherichia coli, Klebsiella, and Proteus mirabilis. In anephric patients, single doses of 250 or 500 mg of cephalexin resulted in high, prolonged serum concentrations. Peak levels were usually observed within 1 hr. However, in two of six anephric patients, peak levels were reached after 6 and 12 hr due to delayed absorption. Hemodialysis for 6 hr reduced the serum concentration of cephalexin by 58%.

Entities:  

Year:  1971        PMID: 16558013      PMCID: PMC416192          DOI: 10.1128/iai.3.4.540-543.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic.

Authors:  M E Levison; W D Johnson; T S Thornhill; D Kaye
Journal:  JAMA       Date:  1969-09-01       Impact factor: 56.272

2.  Oral cephalexin and ampicillin: antimicrobial activity, recovery in urine, and persistence in blood of uremic patients.

Authors:  C M Kunin; Z Finkelberg
Journal:  Ann Intern Med       Date:  1970-03       Impact factor: 25.391

3.  Cephalexin therapy as related to renal function.

Authors:  S A Kabins; B Kelner; E Walton; E Goldstein
Journal:  Am J Med Sci       Date:  1970-02       Impact factor: 2.378

4.  In vitro and in vivo evaluation of cephalexin.

Authors:  H Clark; M Turck
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

5.  Laboratory and clinical experience with cephalexin.

Authors:  A C Kind; D G Kestle; H C Standiford; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968
  5 in total
  4 in total

Review 1.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Pharmacokinetics of cefaclor in patients with end stage renal disease and during hemodialysis.

Authors:  S J Berman; W H Boughton; J G Sugihara; E G Wong; M M Sato; A W Siemsen
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 4.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.